We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 263 results
  1. Osteogenesis imperfecta type 10 and the cellular scaffolds underlying common immunological diseases

    Osteogenesis imperfecta type 10 (OI10) is caused by loss of function codon variants in the gene SERPINH1 that encodes heat shock protein 47 (HSP47),...

    Alan Herbert in Genes & Immunity
    Article 29 May 2024
  2. Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition

    Parkinson’s disease (PD) is usually diagnosed through motor symptoms that make the patient incapable of carrying out daily activities; however,...

    María Teresa Ibarra-Gutiérrez, Norma Serrano-García, Marisol Orozco-Ibarra in Molecular Neurobiology
    Article 03 January 2023
  3. Nutrigenomics in Parkinson’s Disease

    Parkinson’s disease (PD) is the second most common neurodegenerative disease in the world (Ball et al. 2019). PD is characterized by the progressive...
    Chapter 2022
  4. PARK6

    Reference work entry 2018
  5. Platforms for Analyzing Networks of Neurodegenerative and Psychiatric Diseases

    Cellular functions are controlled by genetic networks, and possible mutations in genes produce aberrations in normal cellular activity, disrupting...
    Katerina Kadena, Evgenia Lazarou in Handbook of Computational Neurodegeneration
    Reference work entry 2023
  6. The Role of Ubiquitin–Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease

    Parkinson's disease (PD) is a common neurodegenerative disease that is mainly in middle-aged people and elderly people, and the pathogenesis of PD is...

    Yu Liang, Guangshang Zhong, ... Changqing Liu in NeuroMolecular Medicine
    Article 12 September 2023
  7. Mitophagy Impairments as Culprit of Alzheimer’s Disease

    Dementia is considered as a common term which includes different disease known to affect memory and other cognitive abilities too. Amongst different...
    Shalini Mani, Geeta Swargiary, ... Mahima Rawal in Current Thoughts on Dementia
    Chapter 2022
  8. Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

    Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic Parkinson’s disease (PD). However, strategies aimed at...

    Martin T. Henrich, Wolfgang H. Oertel, ... Fanni F. Geibl in Molecular Neurodegeneration
    Article Open access 11 November 2023
  9. Regulatory Role of ADGRL3, PARK2, and CNTNAP2 in Neurodevelopmental Disorders

    Adhesion G protein-coupled receptors (AGPCRs) are a 33-member subfamily of Class B GPCRs that control many physiological processes and are implicated...
    Vidya Murugesan, Senthilkumar Rajagopal in Proteins Associated with Neurodevelopmental Disorders
    Chapter 2022
  10. Autophagy genes in biology and disease

    Macroautophagy and microautophagy are highly conserved eukaryotic cellular processes that degrade cytoplasmic material in lysosomes. Both pathways...

    Hayashi Yamamoto, Sidi Zhang, Noboru Mizushima in Nature Reviews Genetics
    Article 12 January 2023
  11. Co-editing PINK1 and DJ-1 Genes Via Adeno-Associated Virus-Delivered CRISPR/Cas9 System in Adult Monkey Brain Elicits Classical Parkinsonian Phenotype

    Whether direct manipulation of Parkinson’s disease (PD) risk genes in the adult monkey brain can elicit a Parkinsonian phenotype remains an unsolved...

    Hao Li, Shihao Wu, ... **ntian Hu in Neuroscience Bulletin
    Article Open access 24 June 2021
  12. Genetic Models of Parkinson’s Disease

    Parkinson’s disease (PD) is a chronic and evolving neurodegenerative disorder primarily due to the progressive loss of substantia nigra pars compacta...
    Philippe Kachidian, Paolo Gubellini in Clinical Trials In Parkinson's Disease
    Protocol 2021
  13. Whole-Exome Sequencing Study of Consanguineous Parkinson’s Disease Families and Related Phenotypes: Report of Twelve Novel Variants

    Parkinson’s disease (PD) is a common progressive neurodegenerative disorder with motor and nonmotor symptoms. Recent studies demonstrate various...

    Mohammad Soudyab, Mohammad Shariati, ... Ariane Sadr-Nabavi in Journal of Molecular Neuroscience
    Article 15 December 2022
  14. Platforms for Analyzing Networks of Neurodegenerative and Psychiatric Diseases

    Cellular functions are controlled by genetic networks, and possible mutations in genes produce aberrations in normal cellular activity, disrupting...
    Katerina Kadena, Evgenia Lazarou in Handbook of Computational Neurodegeneration
    Living reference work entry 2022
  15. Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches

    Mitochondria serve as a vital energy source for nerve cells. The mitochondrial network also acts as a defense mechanism against external stressors...

    **ong Yang, Yu Zhang, ... Mei-Hong Lu in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 03 August 2023
  16. Molecular genetics of Parkinson’s disease: Contributions and global trends

    Parkinson’s disease (PD) is a neurodegenerative disorder primarily characterized by motor dysfunction. Aging is the greatest risk factor for...

    Manabu Funayama, Kenya Nishioka, ... Nobutaka Hattori in Journal of Human Genetics
    Article Open access 11 July 2022
  17. Animal Models Used for Studying the Benefits of Probiotics in Neurodegeneration

    Neurodegenerative sicknesses, viz., Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, frontotemporal...
    G. Divyashri, S. G. Prapulla in Probiotic Research in Therapeutics
    Chapter 2022
  18. Based on Virtual Screening and Simulation Exploring the Mechanism of Plant-Derived Compounds with PINK1 to Postherpetic Neuralgia

    Accumulating evidence strongly supports that PINK1 mutation can mediate mitochondrial autophagy dysfunction in dopaminergic neurons. This study was...

    Wen**g Guo, Bo Zhang, ... Yi Feng in Molecular Neurobiology
    Article 11 April 2024
  19. Towards improved screening of toxins for Parkinson’s risk

    Parkinson’s disease (PD) is a chronic, progressive and disabling neurodegenerative disorder. The prevalence of PD has risen considerably over the...

    Ling Shan, Harm J. Heusinkveld, ... Judith R. Homberg in npj Parkinson's Disease
    Article Open access 19 December 2023
Did you find what you were looking for? Share feedback.